Related Experiment Videos
K-ras mutations and prognosis in large-bowel carcinomas
S N Andersen1, T Løvig, J Breivik
1Institute of Forensic Medicine, National Hospital, University of Oslo, Norway.
Scandinavian Journal of Gastroenterology
|January 1, 1997
Summary
K-ras gene mutations are common in colorectal cancer but do not impact patient survival or clinicopathologic variables. The specific K-ras mutation found in primary tumors is consistently present in metastases, regardless of spread type.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) development involves multiple genetic changes.
- K-ras gene mutations occur in approximately 50% of CRC tumors.
- Understanding the role of K-ras mutations is crucial for CRC prognosis.
Purpose of the Study:
- To investigate the association between K-ras gene mutations and survival in colorectal cancer patients.
- To clarify the relationship between K-ras mutations and various clinicopathologic variables.
Main Methods:
- Analysis of 100 large-bowel carcinomas operated on between 1978 and 1982.
- Detection of K-ras point mutations in codons 12 and 13 using PCR, RFLP, and direct sequencing.
Main Results:
- Forty mutations (40%) were identified: 31 in codon 12 and 9 in codon 13.
- No significant correlation was found between K-ras mutations and Dukes' stage, patient age, sex, tumor location, histologic grade, DNA ploidy, or HLA-DR staining.
- Identical K-ras mutation patterns were observed in primary tumors and their corresponding metastases, irrespective of the route of spread.
Conclusions:
- K-ras mutations are homogeneously distributed in primary colorectal tumors.
- The identified K-ras mutation pattern is maintained in secondary tumor deposits.
- K-ras mutation status does not appear to have prognostic significance in colorectal cancer.